Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Barton, James C ^a,b   Barton, Ellen H ^a   Acton, Ronald T ^b,c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYSTEINE; HFE PROTEIN; IRON; TRANSFERRIN; TYROSINE; FERRITIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; AGE; ALCOHOL CONSUMPTION; AMERICAN INDIAN; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GENDER; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON DEPLETION; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PHLEBOTOMY; PLESIOMORPHY; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED STATES; UNIVARIATE ANALYSIS; ADOLESCENT; AGED; AMINO ACID SUBSTITUTION; BLOOD; DRINKING BEHAVIOR; ETHNOLOGY; GENETICS; HOMOZYGOTE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ALABAMA; ALCOHOL DRINKING; AMINO ACID SUBSTITUTION; FEMALE; FERRITINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; INDIANS, NORTH AMERICAN; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; PHLEBOTOMY; TRANSFERRIN;

EID: 33645467950     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-22     Document Type: Article

References (51)

1. Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer JF, Pouchard M, Lafraise B, Brigand A, Caserio-Schoenemann C, Mosser J, Adams P, le Gall JY, David V: Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: A study of 9396 French people. Br J Haematol 2002, 118s1170-1178.
2. Barton JC, Barton NH, Alford TJ: Diagnosis of hemochromatosis probands in a community hospital. Am J Med 1997, 103:498-503.
3. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P: Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005, 352:1769-1778.
4. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS: Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001, 36:1108-1115.
5. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E: Penetrance of hemochromatosis. Blood Cells Mol Dis 2002, 29:418-432.
6. Waalen J, Nordestgaard BG, Beutler E: The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005, 18:203-220.
7. Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C: HAMP as a modifier gene that increases the phenotypic expression of the HIFE pC282Y homozygous genotype. Blood 2004, 103:2835-2840.
8. Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Ferec C: The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 2004, 13:1913-1918.
9. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ: Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003, 12:2241-2247.
10. Cook JD: Hemochromatosis: Effect of iron fortification of foods. In Hemochromatosis: Genetics, pathophysiology, diagnosis and treatment Edited by: Barton JC and Edwards CQ. Cambridge, Cambridge University Press; 2000:535-543.
11. Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs CS: Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst 2005, 97:917-926.
12. Carter K, Bowen DJ, McCune CA, Worwood M: Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: Phenotype and genotype analysis. Br J Haematol 2003, 122:326-332.
13. Beutler E, Gelbart T, Lee P: Haptoglobin polymorphism and iron homeostasis. Clin Chem 2002, 48:2232-2235.
14. Barton JC, Wiener HW, Acton RT, Go RC: HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: Frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis 2005, 34:38-47.
15. Beutler E, Beutler L, Lee PL, Barton JC: The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol Dis 2004, 33:344-345.
16. Beutler E, Gelbart T: Tumor necrosis factor alpha promoter polymorphisms and liver abnormalities of homozygotes for the 845G>A(C282Y) hereditary hemochromatosis mutation. Blood 2002, 100:2268-2269.
17. Lee PL, Ho NJ, Olson R, Beutler E: The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis 1999, 25:374-379.
18. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E: A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001, 27:783-802.
19. Lee PL, Barton JC, Brandhagen D, Beutler E: Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br J Haematol 2004, 127:224-229.
20. Tsuchihashi Z, Hansen SL, Quintana L, Kronmal GS, Mapa FA, Feder JN, Wolff RK. Transferrin receptor mutation analysis in hereditary hemochromatosis patients. Blood Cells Mol Dis 1998, 24:317-321.
21. Barton JC, Acton RT, Lovato L, Speechley MR, McLaren CE, Harris EL, Reboussin DM, Adams PC, Dawkins FW, Gordeuk VR, Walker AP: Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Native Americans and Whites In the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Clin Genet 2006, 69:48.
22. Barton EH, Barton JC, Hollowell WW, Acton RT: Countries of ancestry reported by hemochromatosis probands and control subjects in central Alabama. Ethnicity and Disease 2004, 14:73-81.
23. Barton JC, Acton RT: Inheritance of two HFE mutations in African Americans: Cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency. Genetics in Medicine 2001, 3:294-300.
24. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL: Iron overload in African Americans. American Journal of Medicine 1995, 99:616-623.
25. Barton JC, Acton RT, Rivers CA, Bertoli LF, Gelbart T, West C, Beutler E: Genotypic and phenotypic heterogeneity of African Americans with primary iron overload. Blood Cells Mol Dis 2003, 31:310-319.
26. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV, Group HMW: Management of hemochromatosis. Ann Intern Med 1998, 129:932-939 [http://PM:9867745].
27. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, Rothenberg BE: Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997, 23:135-145.
28. Barton JC, Felitti VJ, Lee P, Beutler E: Characteristics of HFE C282Y homozygotes younger than age 30 years. Acta Haematol 2004, 112:219-221.
29. Hicken BL, Tucker DC, Barton JC: Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol 2003, 98:2072-2077.
30. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, Reboussin DM, McLaren GD, Sholinsky P, Walker AP, Gordeuk VR, Leiendecker-Foster C, Dawkins FW, Eckfeldt JH, Mellen BG, Speechley M, Thomson E: Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003, 325:53-62.
31. Box GEP, Cox DR: An analysis of transformations. J Royal Stat Soc Series 8 (Methodological) 1964, 26:211-252.
32. Phatak PD, Barton JC: Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. Hematology 2003, 8:429-432.
33. Beutler E, Felitti V, Ho NJ, Gelbart T: Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 2002, 107:145-149.
34. Bell H, Skinningsrud A, Raknerud N, Try K: Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med 1994, 236:315-322.
35. Moirand R, Lescoat G, Delamaire D, Lauvin L, Campion JP, Deugnier Y, Brissot P: Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal. Alcohol Clin Exp Res 1991, 15:963-969.
36. Southerland HLJ, Brown JE: The Federal Road through Georgia, the Creek Nation, and Alabama, 1806-1836. Tuscaloosa, The University of Alabama Press; 1989:1-198.
37. Williams WL: Ethnic Life. Cherokees. In Encyclopedia of Southern Culture Edited by: Wilson CR and Ferris W. Chapel Hill, The University of North Carolina Press; 1989:423-424.
38. Paredes JA: Ethnic Life. Creeks. In Encyclopedia of Southern Culture Edited by: Wilson CR and Ferris W. Chapel Hill, The University of North Carolina Press; 1989:426.
39. Pickett AJ: History of Alabama and Incidentally of Georgia and Mississippi, from the Earliest Period 1851. Volume XII. Clerk's Office of the District Court of the United States for the Middle District of Alabama. edition. Edited by: Alabama CODCUSMD. Birmingham, Birmingham Book and Magazine Co. (republisher); 1961:1-685.
40. Alabama State Department of Archives and History: Alabama Census Returns 1820 and An Abstract of Federal Census of Alabama 1830. Alabama Historical Quarterly 1944, Fall Issue:333-513.
41. U.S.Census Bureau.: 2004 [http://factfinder.census.gov].
42. U.S. Census Bureau: 2004 [http://www.census.gov/population/www/ ancestry.html].
43. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996, 245:139-200.
44. Sheth SG, Gordon FD, Chopra S: Nonalcoholic steatohepatitis. Ann Intern Med 1997, 126:137-145.
45. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G: Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001, 96:2448-2455.
46. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992, 102:2108-2113.
47. Kowdley KV: Chronic viral hepatitis and hemochromatosis. In Hemochromatosis. Genetics, pathophysiology, diagnosis and treatment Edited by: Barton JC and Edwards CQ. Cambridge, Cambridge University Press; 2000:387-395.
48. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG: Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 2000, 66:1246-1258.
49. Rossi E, Bulsara MK, Olynyk JK, Cullen DJ, Summerville L, Powell LW: Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem 2001, 47:202-208.
50. Harlow SD, Campbell B: Ethnic differences in the duration and amount of menstrual bleeding during the postmenarcheal period. Am J Epidemiol 1996, 144:980-988.
51. Borwein ST, Ghent CN, Flanagan PR, Chamberlain MJ, Valberg LS: Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med 1983, 6:171-179.